Thomas Grombacher

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Clinical Decision Support

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Pharmacogenomics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Danyi Wang, Jayaprakasam Bolleddula, Anna Coenen-Stass, Thomas Grombacher, Jennifer Q Dong, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities. Pharmacogenomics 25 (4) (2024)
Danyi Wang, Jayaprakasam Bolleddula, Anna Coenen-Stass, Thomas Grombacher, Jennifer Q Dong, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities. Pharmacogenomics 25 (4) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Danyi Wang, Jayaprakasam Bolleddula, Anna Coenen-Stass, Thomas Grombacher, Jennifer Q Dong, Juergen Scheuenpflug, Giuseppe Locatelli, Zheng Feng
Implementation of whole-exome sequencing for pharmacogenomics profiling and exploring its potential clinical utilities. Pharmacogenomics (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Timothy Anthony Yap, Anthony W Tolcher, Ruth Plummer, Jatinder Kaur Mukker, Marta Enderlin, Christine Hicking, Thomas Grombacher, Giuseppe Locatelli, Zoltan Szucs, Ioannis Gounaris, Johann S de Bono
First-in-Human Study of the Ataxia Telangiectasia and Rad3-Related (ATR) Inhibitor Tuvusertib (M1774) as Monotherapy in Patients with Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Astrid Zimmermann, Frank T Zenke, Li-Ya Chiu, Heike Dahmen, Ulrich Pehl, Thomas Fuchss, Thomas Grombacher, Beatrix Blume, Lyubomir T Vassilev, Andree Blaukat
A New Class of Selective ATM Inhibitors as Combination Partners of DNA Double-Strand Break Inducing Cancer Therapies. Molecular cancer therapeutics 21 (6) (2022)